1. Home
  2. PCVX vs BCO Comparison

PCVX vs BCO Comparison

Compare PCVX & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • BCO
  • Stock Information
  • Founded
  • PCVX 2013
  • BCO 1859
  • Country
  • PCVX United States
  • BCO United States
  • Employees
  • PCVX N/A
  • BCO N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • BCO Oil Refining/Marketing
  • Sector
  • PCVX Health Care
  • BCO Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • BCO Nasdaq
  • Market Cap
  • PCVX 4.4B
  • BCO 3.7B
  • IPO Year
  • PCVX 2020
  • BCO N/A
  • Fundamental
  • Price
  • PCVX $36.24
  • BCO $93.33
  • Analyst Decision
  • PCVX Strong Buy
  • BCO Strong Buy
  • Analyst Count
  • PCVX 10
  • BCO 1
  • Target Price
  • PCVX $136.50
  • BCO $138.00
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • BCO 214.7K
  • Earning Date
  • PCVX 08-05-2025
  • BCO 08-06-2025
  • Dividend Yield
  • PCVX N/A
  • BCO 1.09%
  • EPS Growth
  • PCVX N/A
  • BCO 41.25
  • EPS
  • PCVX N/A
  • BCO 3.72
  • Revenue
  • PCVX N/A
  • BCO $5,022,500,000.00
  • Revenue This Year
  • PCVX N/A
  • BCO $3.91
  • Revenue Next Year
  • PCVX N/A
  • BCO $4.45
  • P/E Ratio
  • PCVX N/A
  • BCO $25.18
  • Revenue Growth
  • PCVX N/A
  • BCO 1.97
  • 52 Week Low
  • PCVX $27.66
  • BCO $80.10
  • 52 Week High
  • PCVX $121.06
  • BCO $115.91
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 55.76
  • BCO 56.92
  • Support Level
  • PCVX $35.25
  • BCO $92.59
  • Resistance Level
  • PCVX $37.95
  • BCO $94.55
  • Average True Range (ATR)
  • PCVX 1.54
  • BCO 1.54
  • MACD
  • PCVX 0.14
  • BCO -0.20
  • Stochastic Oscillator
  • PCVX 72.24
  • BCO 48.68

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.

Share on Social Networks: